Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab

PURPOSE: To evaluate the response of intravitreal aflibercept injection (IAI) in eyes with detachment of retinal pigment epithelium (DEP) secondary to nAMD refractory to monthly ranibizumab. PATIENTS AND METHODS: This is a retrospective, multicenter study. All patients received 3 IAI then treated as...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Thi Ha Chau, Dumas, Stéphane, Coscas, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615945/
https://www.ncbi.nlm.nih.gov/pubmed/29093970
http://dx.doi.org/10.1155/2017/8984313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615945/
https://www.ncbi.nlm.nih.gov/pubmed/29093970
http://dx.doi.org/10.1155/2017/8984313

Ejemplares similares